Position in NKTR
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$17,987
+$17,589 QoQ
Shares Held
250
+3471.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MONTAG A & ASSOCIATES INC holds $1,026,657 across 17 Biotechnology names. NKTR ranks #7 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
817 | $364,823 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
750 | $222,727 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
5,013 | $163,123 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
137 | $105,851 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
194 | $101,553 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
542 | $21,848 | |
| 7 | NKTR |
Nektar Therapeutics
This page
|
250 | $17,987 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
80 | $15,124 |
All Filings in NKTR
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,987 | 250 | Shares | Sole | 2026-04-29 | |
| 2025-09-30 | $398 | 7 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||